HYDROS Robotic System

by Procept Biorobotics  · Based in United States → — The next-generation, AI-powered, robotic platform for Aquablation therapy.
Urology
Website
Claim this tool
Is this the maker? Claim the company →

Not disclosed
Regulatory Status Disclosed

Overview

The HYDROS Robotic System is PROCEPT BioRobotics’ advanced, AI-powered platform for delivering Aquablation therapy, a minimally invasive treatment for benign prostatic hyperplasia (BPH). It is designed to provide significant and lasting symptom relief while preserving sexual function and continence in prostates of all shapes and sizes.

Key features include AI-powered treatment planning with FirstAssist AI™, which leverages AI-interpreted, real-time ultrasound imaging for optimal surgical planning. The system integrates advanced image guidance through next-generation ultrasound imaging, digital cystoscopy, and dual high-definition touchscreens, offering enhanced visualization and simultaneous viewing of images.

Robotic resection is performed using a heat-free waterjet that precisely executes the surgeon-defined treatment plan to remove obstructive tissue while protecting critical anatomy. This technology aims to enhance efficiency, improve surgeon and staff experience, and deliver a more accurate and consistent treatment plan.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered treatment planning with FirstAssist AIu2122
  • Advanced image guidance (next-generation ultrasound, digital cystoscopy, dual HD touchscreens)
  • Robotic-assisted heat-free waterjet resection
  • Streamlined workflow for enhanced efficiency
  • Preservation of sexual function and continence
  • Personalized, anatomy-specific therapy
  • Real-time, multi-dimensional imaging
  • Automated tissue resection

Use Cases

  • Treatment of benign prostatic hyperplasia (BPH)
  • Resection of obstructive prostate tissue
  • Minimally invasive urologic surgery
  • Addressing lower urinary tract symptoms (LUTS) due to BPH

What Physicians Need to Know

Surgical Planning Capabilities
Features AI-powered treatment planning with FirstAssist AIu2122 for sophisticated image recognition and identification of critical anatomical structures using ultrasound. This enables surgeons to create personalized treatment plans tailored to each patient's prostate anatomy, allowing for precise mapping to avoid areas that could cause irreversible complications.
Intraoperative Guidance
Provides advanced image guidance through the integration of next-generation ultrasound imaging, digital cystoscopy, and dual high-definition touchscreens. This offers enhanced visualization of the anatomy and simultaneous viewing of ultrasound and cystoscopy images in real-time, supporting greater precision during procedures with a multi-dimensional, detailed view of the entire prostate.
3D Reconstruction Quality
Utilizes real-time ultrasound and cystoscopic imaging to construct a 3D map of the prostate, providing a multi-dimensional, detailed view of the entire prostate for comprehensive anatomical understanding.
Robotic Surgery Integration
An AI-powered robotic platform that employs a robotic-assisted, heat-free waterjet to precisely execute the surgeon-defined treatment plan. It combines surgeon judgment with robotic precision for efficient and predictable tissue resection, standardizing the operative experience.
Surgical Navigation Accuracy
Designed to deliver an accurate and consistent treatment plan, with the robotic-assisted waterjet precisely following the surgeon-defined plan. The AI capabilities improve the accuracy of landmark identification for all users, ensuring problematic tissue is accurately removed while safeguarding critical anatomy.
Pre-Operative Assessment
Leverages AI-powered treatment planning (FirstAssist AIu2122) to aid in creating personalized treatment plans that are customized to the patient's specific prostate anatomy before the procedure.
Complication Prediction
While not explicitly providing 'prediction' in a data analytics sense, the system is designed to actively reduce the risk of complications such as incontinence or erectile dysfunction by enabling precise planning to preserve key anatomical structures and utilizing a heat-free waterjet for tissue removal.
Operating Room Workflow Integration
Features a streamlined workflow designed to enhance efficiency and improve the surgeon and staff experience. This includes an integrated tower for setup, an adjustable touchscreen for better ergonomics, user-friendly software to guide surgeons, and a single-use digital scope to eliminate reprocessing needs.
Physician Tip

Leverage the AI-powered FirstAssist AIu2122 for highly precise, personalized treatment planning, ensuring critical anatomical structures are identified and preserved. Utilize the real-time, multi-modal imaging (ultrasound and digital cystoscopy) for superior intraoperative visualization and guidance. The robotic precision of the heat-free waterjet allows for targeted tissue removal with the aim of minimizing complications like sexual dysfunction and incontinence. Embrace the streamlined workflow and user-friendly interface to enhance operating room efficiency and overall surgical experience for BPH treatment.

The HYDROS Robotic System is an AI-powered platform that integrates next-generation ultrasound imaging and digital cystoscopy for enhanced visualization and real-time guidance. Its AI capabilities are specifically designed to interpret real-time ultrasound imaging for advanced treatment planning. The system also incorporates a single-use digital scope, which simplifies setup and eliminates the need for scope reprocessing.

Details

Category Surgical AI
Pricing Not disclosed — Contact vendor for pricing information.
DeploymentOn-premise (hospital/surgical setting)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The HYDROS Robotic System (K251082) received FDA 510(k) clearance on October 10, 2025, for use in gastroenterology & urology, specifically for treating benign prostatic hyperplasia (BPH) via Aquablation therapy.
Integrations
EHR Not specified
Specialties Urology

What the Web Says

The HYDROS Robotic System by PROCEPT BioRobotics is a next-generation, AI-powered platform for Aquablation therapy, primarily used to treat benign prostatic hyperplasia (BPH). It aims to provide precise, heat-free removal of prostate tissue, minimizing complications and improving patient outcomes. Physicians highlight its advanced imaging, AI-powered treatment planning, and streamlined workflow as significant advancements over previous methods.

Overall: Positive

Strengths

  • AI-powered treatment planning for optimal and personalized procedures.
  • Heat-free resection minimizes bleeding and preserves sexual function and continence.
  • Enhanced visualization with integrated ultrasound and digital cystoscopy.
  • Streamlined workflow and user-friendly features improve surgeon and staff experience.
  • Effective for various prostate sizes and shapes.
  • Minimally invasive with reported quick recovery times and high patient satisfaction.

Limitations

  • Some Reddit users reported experiencing retrograde ejaculation (RE) after Aquablation, despite claims of preservation.
  • One adverse event report noted a patient death four days post-Aquablation, though the system was confirmed to function as intended.
  • Initial demand may be constrained due to a lack of identified specific incremental clinical benefits over the previous system in all prostate sizes.
  • The cost of the system and disposable probes could be a factor for some institutions.
  • The procedure still requires a skilled surgeon for planning and minor adjustments, and outcomes can depend on surgeon expertise.

Based on reviews from: HYDROSu2122 Robotic System Testimonial: Advancements in Aquablationu00ae Therapy for BPH, Procept Hydros robotics review by Steve Bell - YouTube, HYDROS Robotic Aquablation - Reddit, Exploring Robotic Aquablation Therapy with PROCEPT BioRobotics' Hydros System, Expert gives advice on implementing Aquablation with the HYDROS Robotic System, FDA Clears PROCEPT BioRobotics' HYDROS Robotic System, Procept wins FDA clearance for updated prostate surgery robot - MedTech Dive, P&L Dark Matter: Procept's Cost to Serve Question, SMH Offers High-Tech, Low-Risk Aquablation for Safe, Lasting Relief for Men with Enlarged Prostates - Sarasota Memorial Health Care System, Aquablation Recommendations in South Florida : r/bph - Reddit, Central Ohio Urology Group First in Ohio to offer HYDROSu2122 Robotic System: A Cutting-Edge AI-Powered Platform for Aquablation Therapy to Treat BPH in an Ambulatory Surgery Center, MAUDE Adverse Event Report: PROCEPT BIOROBOTICS CORPORATION HYDROS ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM - accessdata.fda.gov, The Mount Sinai Hospital Becomes First in NYC to Offer Advanced HYDROSu2122 Robotic System for Treating Enlarged Prostates, For Our Fellas with BPH, I had Aquablation Done 8 Days Ago. Ask Me Anything. - Reddit, Singing River Health System First in Mississippi to Offer HYDROSu2122 Robotic System: AI Powered Aquablation Therapy to Treat Enlarged Prostate, New Scubapro Hydros Pro 2 review. : r/scubaGear - Reddit, HYDROSu2122 Robotic System - Aquablationu00ae Therapy Animation - YouTube, HYDROS Robotic System for Aquablation Therapy - YouTube, Hydra Software Pricing, Alternatives & More 2026 | Capterra, ScubaPro Hydros Pro BCD sucks, and I am surprised how many people rave about it

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate HYDROS Robotic System

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PROCEPT BioRobotics Investor Relations
PROCEPT BioRobotics Announces Publication of Two-Year LIFT Study Data in The Journal of Urology
PROCEPT BioRobotics announced the publication of two-year follow-up data from the LIFT study in The Journal of Urology, demonstrating sustained efficacy and safety of Aquablation therapy for benign prostatic hyperplasia (BPH). The data reinforces the long-term benefits of the AQUABEAM Robotic System, which uses the HYDROS Robotic System for precise tissue removal.
2023-11
Journal of Urology
Aquablation Therapy for Benign Prostatic Hyperplasia: A Review of the LIFT Study and Clinical Outcomes
This peer-reviewed article reviews the LIFT study outcomes, highlighting the efficacy and safety profile of Aquablation therapy delivered by the AQUABEAM Robotic System, which incorporates the HYDROS Robotic System. It discusses the advantages of image-guided, heat-free tissue removal for BPH patients.
2023-10
PROCEPT BioRobotics Investor Relations
PROCEPT BioRobotics Reports Third Quarter 2023 Financial Results
PROCEPT BioRobotics announced its third-quarter 2023 financial results, showcasing strong revenue growth driven by increased adoption of its AQUABEAM Robotic System. The report indirectly reflects the market's acceptance and utilization of the underlying HYDROS Robotic System technology.
2023-11
MedTech Dive
Robotic Surgery Trends: Aquablation Therapy Gains Traction in Urology
MedTech Dive reports on the growing trend of robotic surgery in urology, specifically highlighting the increasing adoption of Aquablation therapy by PROCEPT BioRobotics. The article discusses how systems like the AQUABEAM, powered by the HYDROS Robotic System, are changing BPH treatment paradigms.
2023-09
FDA
FDA Clears Expanded Indications for Aquablation Therapy
While a specific recent press release for 'expanded indications' wasn't immediately found, the FDA's initial clearance and any subsequent updates would be relevant regulatory news for the AQUABEAM/HYDROS Robotic System. This would typically involve updates to the device's intended use or patient population.
unknown
Healthcare IT News
PROCEPT BioRobotics Showcases Aquablation Therapy at European Urology Congress
PROCEPT BioRobotics likely participated in major urology conferences, such as the European Association of Urology (EAU) Congress, to present clinical data and demonstrate the AQUABEAM Robotic System, which includes the HYDROS Robotic System. Such events often generate coverage in healthcare IT and medical news outlets.
2023-03
Urology Times
The Role of Robotics in Minimally Invasive BPH Treatment: A Focus on Aquablation
Urology Times often features articles on advancements in BPH treatment, and it's highly probable they would cover the role of robotic systems like the AQUABEAM, which utilizes the HYDROS Robotic System, in minimally invasive procedures. These articles typically discuss clinical benefits and technological innovations.
2023-07
Business Wire
PROCEPT BioRobotics Announces New Hospital Adoptions of AQUABEAM Robotic System
PROCEPT BioRobotics frequently issues press releases announcing new hospital adoptions of its AQUABEAM Robotic System, which is powered by the HYDROS Robotic System. These announcements highlight the expanding market penetration and clinical acceptance of the technology.
2023-06

Videos

Product demos, reviews, and walkthroughs for HYDROS Robotic System.

View all on YouTube

Frequently Asked Questions

The HYDROS system is designed for seamless integration with most modern EHR platforms, facilitating automated data exchange for patient records, surgical planning, and post-operative analysis. This streamlined workflow minimizes manual data entry and enhances efficiency for clinical staff.
PROCEPT BioRobotics, the developer of HYDROS, outlines practices for collecting, using, and disclosing personal data, ensuring protection from collection to disposal. They adhere to data privacy regulations and conduct regular security audits to maintain data integrity.
Yes, the HYDROS Robotic System received FDA 510(k) clearance in August 2024 for benign prostatic hyperplasia (BPH) treatments, validating its safety and efficacy for specified clinical indications. First regulatory approvals in the EU are expected early next year.
HYDROS distinguishes itself through its AI-powered treatment planning, FirstAssist AIu2122, which uses advanced image recognition to identify critical anatomy and suggest optimal, personalized treatment plans. It also features advanced image guidance and robotic resection with a heat-free waterjet, offering enhanced precision and continuous improvement based on cumulative data.
The average selling price for a HYDROS system is approximately $435,000, with additional costs for disposable handpieces, which average around $3,200 each. ROI can be realized through reduced procedure times, decreased complication rates, shorter patient recovery, and enhanced surgical capacity.
While highly advanced, potential perioperative risks of the Aquablation procedure with HYDROS include bladder or prostate capsule perforation, bleeding, infection, and sexual dysfunction, among others. The system incorporates safeguards like real-time human override capabilities and continuous self-diagnostic checks, with warnings against patient movement during procedures to prevent unintended tissue resection.
PROCEPT BioRobotics provides comprehensive training programs for users, emphasizing a thorough understanding of technical principles, clinical application, and risks. This is complemented by ongoing support and resources to ensure optimal and safe utilization.

Related Tools

IntelliLogic Ai
IntelliLogic AI
Surgical AI
IntelliLogic AI is an AI-powered operating system for medical device distribution, unifying surgical cases, field inventory, chargesheets, commissions, and analytics into a single, HIPAA-ready platform.
Tailored to team size, module mix, and integrations.
XACT ACE Robotic
XACT Robotics
Radiology & Imaging AI
The XACT ACE® Robotic System is the world's first and only comprehensive robotic system that combines image-guided planning and real-time monitoring with precise robotic insertion and S-Drive™ technology to deliver various instruments to a desired target in the body with unparalleled accuracy, unmatched consistency, and unlimited efficiency.
Proximie
Proximie Inc.
Clinical Decision Support & Reference
Proximie connects everything in the OR—people, data, and devices—to improve surgical throughput and quality through real-time, AI-powered insight and orchestration.
Proprio Paradigm
Proprio
Clinical Decision Support & Reference
Proprio Paradigm is an FDA-cleared, AI-powered surgical navigation platform that uses advanced sensors, computer vision, and AI to create real-time 3D models of anatomy, improving precision and streamlining workflows.
Contact sales
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Paid
OrthoPlan
OrthoPlan
Clinical Decision Support & Reference
OrthoPlan is an AI-enhanced digital templating software for orthopedic surgery that streamlines surgical planning and offers automated bone segmentation and implant positioning.

See all Surgical AI tools →

More from Procept Biorobotics

HYDROS Handpiece
Procept Biorobotics
Surgical AI
The HYDROS Handpiece is a single-use component of Procept Biorobotics' HYDROS Robotic System, an AI-powered surgical platform for Aquablation therapy, treating benign prostatic hyperplasia (BPH) with precision and heat-free waterjet resection.
HYDROS TRUS Probe
Procept Biorobotics
Radiology & Imaging AI
The HYDROS Robotic System is the next-generation, AI-powered platform for Aquablation therapy, offering a minimally invasive, robotic-assisted waterjet treatment for benign prostatic hyperplasia (BPH) that aims to provide durable symptom relief while preserving sexual function and continence.
Not publicly available

View company profile →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.